Quantinno Capital Management
UTHR icon

Quantinno Capital Management’s United Therapeutics UTHR Stock Holding History

Quantinno Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.8M Buy
36,559
+9,437
+35% +$4.88M 0.02% 821
2026
Q2 		$14.7M Buy
27,122
+5,987
+28% +$3.37M 0.02% 826
2026
Q1 		$12.5M Buy
21,135
+3,479
+20% +$1.73M 0.02% 787
2025
Q4 		$8.6M Buy
17,656
+7,994
+83% +$3.72M 0.02% 842
2025
Q3 		$4.05M Buy
9,662
+5,582
+137% +$1.88M 0.01% 987
2025
Q2 		$1.17M Buy
4,080
+1,035
+34% +$309K 0.01% 1264
2025
Q1 		$939K Buy
3,045
+734
+32% +$252K 0.01% 1173
2024
Q4 		$815K Buy
2,311
+1,003
+77% +$369K 0.01% 1109
2024
Q3 		$469K Buy
1,308
+322
+33% +$109K 0.01% 1145
2024
Q2 		$314K Buy
+986
New +$261K 0.01% 1143
2020
Q1 		– Sell
-4,170
Closed -$367K – 559
2019
Q4 		$367K Sell
4,170
-1,376
-25% -$121K 0.23% 196
2019
Q3 		$442K Buy
+5,546
New +$447K 0.3% 133
2019
Q2 		– Sell
-4,267
Closed -$501K – 524
2019
Q1 		$501K Buy
4,267
+1,592
+60% +$186K 0.32% 112
2018
Q4 		$291K Buy
+2,675
New +$310K 0.24% 213

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Quantinno Capital Management's UTHR Position: Q3 2026 in Review

Quantinno Capital Management increased its United Therapeutics (UTHR) stake by 35% in Q3 2026, buying an estimated $4.88M and bringing the position to 36,559 shares worth $19.8M. The position accounts for 0.02% of the portfolio, ranked #821.

Quantinno Capital Management first reported a position in UTHR in Q4 2018 and has held it in 14 quarters since. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Quantinno Capital Management held 36,559 shares of United Therapeutics worth $19.8M as of Q3 2026.
  • Quantinno Capital Management bought 9,437 United Therapeutics shares in Q3 2026, an estimated $4.88M.
  • United Therapeutics made up 0.02% of Quantinno Capital Management's portfolio in Q3 2026, its #821 holding.
  • Quantinno Capital Management first reported a position in United Therapeutics in Q4 2018 and has held it in 14 quarters since.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.